p. 6989−6999
2476-762X
Vol.15/No.17
p. 7001−7010
2476-762X
Vol.15/No.17
p. 7011−7014
2476-762X
Vol.15/No.17
p. 7015−7019
2476-762X
Vol.15/No.17
p. 7021−7027
2476-762X
Vol.15/No.17
p. 7029−7035
2476-762X
Vol.15/No.17
p. 7037−7041
2476-762X
Vol.15/No.17
p. 7043−7048
2476-762X
Vol.15/No.17
p. 7049−7054
2476-762X
Vol.15/No.17
p. 7055−7059
2476-762X
Vol.15/No.17
p. 7061−7064
2476-762X
Vol.15/No.17
p. 7065−7068
2476-762X
Vol.15/No.17
p. 7069−7077
2476-762X
Vol.15/No.17
p. 7079−7083
2476-762X
Vol.15/No.17
0.05). Conclusions: FTA card is a promising sample carrier for cervical cancer screening. With appropriate education programmes and further optimization of the experimental workflow, FTA card based self-collection in combination withcentralized careHPVTM testing can help expand the coverage of cervical cancer screening in low-resource areas.]]>
p. 7085−7090
2476-762X
Vol.15/No.17
p. 7091−7095
2476-762X
Vol.15/No.17
p. 7097−7103
2476-762X
Vol.15/No.17
p. 7105−7112
2476-762X
Vol.15/No.17
p. 7113−7118
2476-762X
Vol.15/No.17
p. 7119−7123
2476-762X
Vol.15/No.17
p. 7125−7128
2476-762X
Vol.15/No.17
p. 7129−7135
2476-762X
Vol.15/No.17
p. 7137−7139
2476-762X
Vol.15/No.17
p. 7141−7148
2476-762X
Vol.15/No.17
p. 7149−7152
2476-762X
Vol.15/No.17
p. 7153−7158
2476-762X
Vol.15/No.17
p. 7159−7162
2476-762X
Vol.15/No.17
p. 7163−7167
2476-762X
Vol.15/No.17
A) with Risk of Chronic Lymphocytic Leukemia]]>
A) in the NPAS2 gene was genotyped and melatonin concentrations were measured in a total of seventy-four individuals, including thirty-seven CLL cases and an equal number of age- and sex-matched healthy controls in order to examine the effect of NPAS2 polymorphism and melatonin concentrations on CLL risk in a Pakistani population. Materials and Methods: Genotyping of rs2305160:G>A polymorphism at NPAS2 locus was carried out by amplificationrefractory mutation system-polymerase chain reaction (ARMS-PCR). Melatonin concentrations were determined by enzyme linked immunosorbent assay (ELISA). Statistical analysis was performed using Statistical Packagefor Social Sciences software. Results: Our results demonstrated no association of the variant Thr genotypes (Ala/ Thr and Thr/Thr) with risk of CLL. Similarly, no association of rs2305160 with CLL was observed in either females or males after stratification of study population on a gender basis. Moreover, when the subjects with CLL were further stratified into shift-workers and non-shift-workers, no association of rs2305160 with CLL was seen in either case. However, significantly low serum melatonin levels were observed in CLL patients as compared to healthy subjects (p<0.05). Also, lower melatonin levels were seen in shift-workers as compared to non-shift-workers (p<0.05). There was no significant difference (p>0.05) in the melatonin levels across NPAS2 genotypes in all subjects, subjects with CLL who were either shift workers or non-shift-workers. General Linear Model (GLM) univariate analysis revealed no significant association (p>0.05) of the rs2305160 polymorphism of the NPAS2 gene with melatonin levels in any of the groups. Conclusions: While low melatonin levels and shift-work can be considered as one of the risk factors for CLL, the NPAS2 rs2305160 polymorphism does not appear to have any association with risk of CLL in our Pakistani population.]]>
p. 7169−7174
2476-762X
Vol.15/No.17
p. 7175−7180
2476-762X
Vol.15/No.17
p. 7181−7185
2476-762X
Vol.15/No.17
p. 7187−7193
2476-762X
Vol.15/No.17
1000 ng/mL) not only increased patient PFS and OS but also reduced tumor metastasis. Patients with mutant EGFR experienced a higher median PFS and OS (234 and 627 days), especially those with the 19del genotype demonstrating higher PR ratio. Patients who suffered grade II skin toxicity had a higher icotinib exposure than those with grade I skin toxicity or no adverse effects. Liver toxic reactions might occur in patients with greater M20 and M23 plasma concentrations. Conclusions: CYP2C19polymorphisms significantly affect icotinib, M24 and M26 exposure. Patients with mutant EGFR genotype and higher icotinib concentration might have increased PFS and OS and lower tumor metastasis. Liver ADR events and serious skin effects might be respectively induced by greater M20, M23 and icotinib concentrations.]]>
p. 7195−7200
2476-762X
Vol.15/No.17
p. 7201−7205
2476-762X
Vol.15/No.17
p. 7207−7211
2476-762X
Vol.15/No.17
p. 7213−7218
2476-762X
Vol.15/No.17
p. 7219−7222
2476-762X
Vol.15/No.17
p. 7223−7228
2476-762X
Vol.15/No.17
p. 7229−7234
2476-762X
Vol.15/No.17
p. 7235−7239
2476-762X
Vol.15/No.17
p. 7241−7244
2476-762X
Vol.15/No.17
p. 7245−7249
2476-762X
Vol.15/No.17
p. 7251−7255
2476-762X
Vol.15/No.17
p. 7257−7261
2476-762X
Vol.15/No.17
0.05). Conclusions:This study suggested that mothers had very little information on HPV and HPV vaccination. Knowledge of the disease and its vaccination is an essential factor for the success of the vaccination program. It is of great importance that mothers are trained in this subject by health professionals.]]>
p. 7263−7266
2476-762X
Vol.15/No.17
p. 7267−7270
2476-762X
Vol.15/No.17
p. 7271−7275
2476-762X
Vol.15/No.17
p. 7277−7280
2476-762X
Vol.15/No.17
70 when the rate for Chinese women overtook their Malay counterpart. Conclusions: Our study showed that there is a declining trend in the incidence of gastric cancer and higher rates were observed in men and Chinese.]]>
p. 7281−7285
2476-762X
Vol.15/No.17
p. 7287−7290
2476-762X
Vol.15/No.17
p. 7291−7296
2476-762X
Vol.15/No.17
p. 7297−7301
2476-762X
Vol.15/No.17
p. 7303−7307
2476-762X
Vol.15/No.17
p. 7309−7316
2476-762X
Vol.15/No.17
p. 7317−7320
2476-762X
Vol.15/No.17
p. 7321−7326
2476-762X
Vol.15/No.17
3, elevated GGT and elevated CEA were confirmed as independent risk factors which could predict poor prognosis. Patients could be divided into three groups according to the number of risk factors they had. Those with two or three were defined as thehigh risk group, individuals with one risk factor as the modest risk group and patients without risk factor as the low risk group. The OS values for these three groups were 16.2 months (2.80~68.8), 24.2 months (4.07~79.0), and 37.2 months (12.6~87.8), respectively (p<0.001). Conclusions: We developed a simple but useful model based on NLR, GGT and CEA to provide prognostic information to clinical practice in highly selected mCRC patients. Further prospective and multi-center studies are warranted to test our model.]]>
p. 7327−7331
2476-762X
Vol.15/No.17
60 year-old group (55.0%), and the second was within the 51-55 year-old group (50.0%) (χ2=19.497, p<0.05). HPV 16 was the most prevalent genotype (9.2%), followed by HPV 52 (7.8%), HPV 6 (6.9%), HPV 11 (5.9%) and HPV 42 (5.0%). The single type HPV infection was 30.4%, with the five majority prevalent genotype HPV 16 (16.5%), HPV 52 (14.3%), HPV 6 (12.6%), HPV42 (8.6%), HPV 31 (5.1%). The multiple-type HPV infections were 14.0%, and HPV 16 was the most prevalent type (29.6%), followed by HPV 52 (24.7%), HPV 6 (22.2%), HPV 11 (22.2%), HPV 42 (17.3%) and HPV 39 (17.3%).]]>
p. 7333−7336
2476-762X
Vol.15/No.17
p. 7337−7341
2476-762X
Vol.15/No.17
p. 7343−7350
2476-762X
Vol.15/No.17
0.05). Conclusions: To our knowledge, this is the first study investigating NLR in BLL, PLL and LSCC. NLR is an inexpensive, reproducible and widely available blood test, and could be a useful inflammatory marker to differentiate LSCC from BLL and PLL.]]>
p. 7351−7355
2476-762X
Vol.15/No.17
p. 7357−7362
2476-762X
Vol.15/No.17
p. 7363−7369
2476-762X
Vol.15/No.17
p. 7371−7375
2476-762X
Vol.15/No.17
0.001) in their genotype distributions. The three major indigenous ethnic groups in Sabah show unique genotype distributions when compared with other populations. This finding indicates the importance of establishing the genotype distributions of CYP2E1 PstI polymorphism in the indigenous populations.]]>
p. 7377−7381
2476-762X
Vol.15/No.17
p. 7383−7387
2476-762X
Vol.15/No.17
p. 7389−7394
2476-762X
Vol.15/No.17
p. 7395−7399
2476-762X
Vol.15/No.17
p. 7401−7405
2476-762X
Vol.15/No.17
p. 7407−7411
2476-762X
Vol.15/No.17
p. 7413−7417
2476-762X
Vol.15/No.17
p. 7419−7424
2476-762X
Vol.15/No.17
p. 7425−7432
2476-762X
Vol.15/No.17
p. 7433−7436
2476-762X
Vol.15/No.17
p. 7437−7441
2476-762X
Vol.15/No.17
0.05), likely due to the smaller sample size. Conclusions: Although this was a small-scale negative study, to our knowledge, we have conducted the first GWAS for BCC risk in an Asian population. Further large studies in non-Caucasian populations are required to achieve statistical significance and confirm these findings.]]>
p. 7443−7447
2476-762X
Vol.15/No.17
p. 7449−7452
2476-762X
Vol.15/No.17
p. 7453−7457
2476-762X
Vol.15/No.17
p. 7459−7465
2476-762X
Vol.15/No.17
p. 7467−7471
2476-762X
Vol.15/No.17
p. 7473−7478
2476-762X
Vol.15/No.17
p. 7479−7486
2476-762X
Vol.15/No.17
p. 7487−7488
2476-762X
Vol.15/No.17